Abstract
Purpose
Apoptosis is a highly regulated mechanism of cell death where pro-apoptotic proteins and caspases play an important role. Activation of pro-caspases at a definite time is essential to control the whole caspase cascade. Mitochondrion contains some pro-apoptotic proteins, which need to come out in cytoplasm for apoptotic function such as Cytochrome c (Cyt c), while the Bcl-2 protein family works as the guard of mitochondrial membrane and prevents the escape of Cyt c. Once Cyt c is out in cytoplasm, it binds with Apaf-1 (another pro-apoptotic protein also essential for proper cell differentiation) and pro-caspase-9, forming the Apoptosome complex. In this study, the role of two non-steroidal anti-inflammatory drugs (NSAIDs), Diclofenac and Celecoxib, in experimentally induced early neoplasm of colon via apoptosome mechanism had been studied. It has been recognized that the prolonged use of NSAIDs has its effect on reducing the risk of colorectal cancer through apoptotic pathways. However, the role of NSAIDs in respect of apoptosome is not clear.
Methods
Western blotting and immunohistochemistry were performed, along with morphological and histological analysis.
Results
According to the expression levels of Cytochrome c, Apaf-1, Caspases, and Bcl-2, it was observed that NSAIDs do follow the mitochondrial or intrinsic pathway of apoptosis.
Conclusion
The effects of Diclofenac and Celecoxib on the expression of pro- and anti-apoptotic proteins have been observed, which may constitute the mechanism by which the NSAIDs are efficient in controlling the proliferation of neoplasm in the colon.
Similar content being viewed by others
References
Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res. 1996;2:1999–2006.
Brown JR, DuBois RN. COX-2: A molecular target for colorectal cancer prevention. J Clin Oncol. 2005;23:2840–55. doi:10.1200/JCO.2005.09.051.
Thun MJ, Henley SJ, Patron C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–66.
Hwang DH, Fung V, Dannenberg AJ. National cancer institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: Role of COX-dependent and -independent mechanisms. Neoplasia. 2002;4:91–7. doi:10.1038/sj/neo/7900226.
Ricchi P, Matola TD, Ruggiero G, et al. Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs. Br J Cancer. 2002;86:1501–9. doi:10.1038/sj/bjc/6600289.
Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063–73.
Jana NR. NSAIDs and apoptosis. Cell Mol Life Sci. 2008;65:1295–301.
Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible Nitric Oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 2002;62:165–70.
Kanwar SS, Vaipei K, Nehru B, Sanyal SN. Antioxidative effects of non-steroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rat. J Environ Pathol Toxicol Oncol. 2008;27:89–100.
Vaish V, Tanwar L, Sanyal SN (2010) The role of NF-kappaB and PPARgamma in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. Tumour Biol. 2010 Jun 1. [Epub ahead of print]. doi: 10.1007/s13277-010-0051-7.
Hirose Y, Kuno T, Yamada Y, et al. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis. 2003;24:107–11.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
Ochiai M, Ushigome M, Fujiwara K, et al. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Am J Pathol. 2003;163:1607–14.
Rodrigues MAM, Silva LAG, Salvadori DMF, de Camargo JLV, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002;35:351–5.
Marsden VS, O’Connor L, O’Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419:634–7. doi:10.1038/nature01101.
Chipuk JE, Bouchier HL, Green DR. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 2006;13:1396–402. doi:10.1038/sj.cdd.4401963.
Oberst A, Bender C, Green DR. Living with death: The evolution of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 2008;15:1139–46. doi:10.1038/cdd.2008.65.
Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in Apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophys J. 2006;90:1546–59. doi:10.1529/biophysj.105.068122.
Wang S, Yan NY, Cai R, Alimov I, Cohen D. Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle. 2006;5:1662–8.
Zou H, Li Y, Liu X, Wang X. An Apaf-1·Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274:11549–56.
Ho AT, Zacksenhaus E. Splitting the Apoptosome. Cell Cycle. 2004;3:446–8.
Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S. A novel enhancer of the Apaf1 Apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem. 2001;276:9239–45. doi:10.1074/jbc.M006309200.
Purring KC, McLendon G. Cytochrome c binding to Apaf-1: The effects of dATP and ionic strength. Proc Natl Acad Sci. 2000;97:11928–31.
Johnson CE, Huang YY, Parrish AB, et al. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci. 2007;104:20820–5.
Cecconi F, Gruss P. Apaf1 in developmental apoptosis and cancer: how many ways to die? Cell Mol Life Sci. 2001;58:1688–97.
Saikumar P, Mikhailova M, Pandeswara SL. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front Biosci. 2007;12:3343–54.
Chinnaiyan AM. The Apoptosome: Heart and soul of the cell death machine. Neoplasia. 1999;1:5–15.
Hausmann G, O’Reilly LA, van Driel R, et al. Pro-apoptotic apoptosis protease–activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-xL. J Cell Biol. 2000;149:623–33.
Kim HE, Du F, Fang M, Wang X. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci. 2005;102:17545–50.
Bratton SB, Walker G, Srinivasula SM, Sun XM, et al. Recruitment, activation and retention of caspase-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001;20:998–1009.
Citterio S, Sgorbati S, Levi M, Colombo BM, Sparvoli E. PCNA and total nuclear protein content as markers of cell proliferation in pea tissue. J Cell Sci. 1992;102:71–8.
Acknowledgements
Financial assistance from the Department of Science and Technology, Govt. of India (SR/SO/BB-05/2008), is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vaish, V., Tanwar, L., Kaur, J. et al. Chemopreventive Effects of Non-steroidal Anti-inflammatory Drugs in Early Neoplasm of Experimental Colorectal Cancer: an Apoptosome Study. J Gastrointest Canc 42, 195–203 (2011). https://doi.org/10.1007/s12029-010-9188-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9188-2